Subjects: TRANSPLANTES, CÉLULAS-TRONCO
ABNT
PINTO, Mariana Bitu Ramos et al. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial. v. No 2021, n. 11, p. 6495-6503, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00520-021-06228-3. Acesso em: 15 out. 2024.APA
Pinto, M. B. R., Gusmão, T. P. de L., Schmidt‑Filho, J., Jaguar, G. C., Martins, M. D., & Alves, F. A. (2021). Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial, No 2021( 11), 6495-6503. doi:10.1007/s00520-021-06228-3NLM
Pinto MBR, Gusmão TP de L, Schmidt‑Filho J, Jaguar GC, Martins MD, Alves FA. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial [Internet]. 2021 ; No 2021( 11): 6495-6503.[citado 2024 out. 15 ] Available from: https://doi.org/10.1007/s00520-021-06228-3Vancouver
Pinto MBR, Gusmão TP de L, Schmidt‑Filho J, Jaguar GC, Martins MD, Alves FA. Intraoral versus extraoral photobiomodulation therapy in the prevention of oral mucositis in HSCT patients: a randomized, single-blind, controlled clinical trial [Internet]. 2021 ; No 2021( 11): 6495-6503.[citado 2024 out. 15 ] Available from: https://doi.org/10.1007/s00520-021-06228-3